Jalen Hurts expected to miss remainder of 2026 season due to blood clot
Jalen Hurts expected to miss remainder of 2026 season due to blood clot
Glenn Erby , Eagles WireMon, October 19, 2026 at 2:16 PM UTC
0
The Eagles and agent Nicole Lynn confirmed Jalen Hurts has blood clots in both lungs. He is clinically stable and expected to recover fully
Jalen Hurts is facing an extended absence after additional testing revealed deep vein thrombosis and blood clots in both lungs, the Eagles and his agent, Nicole Lynn, announced in a joint statement Monday. Philadelphia said its quarterback is clinically stable, has no significant functional limitations and is expected to make a full recovery.
Hurts is expected to be sidelined for multiple months and is unlikely to play again this season, according to the reporting accompanying the announcement. The team and Lynn did not announce a specific return date or formally rule him out for the remainder of the season.
The statement provided a fuller account of a condition initially diagnosed while the Eagles were in London. Specialists first diagnosed Hurts with a left calf superficial vein thrombosis. Further testing and monitoring established the current diagnosis of deep vein thrombosis and bilateral pulmonary emboli, meaning blood clots in both lungs.
The Eagles and Lynn said Hurts has undergone comprehensive evaluations by physician experts over the last few days. His treatment is expected to involve anticoagulation, commonly known as blood thinners, and he will not be permitted to participate in contact activities, including football, during that treatment.
The restriction makes his medical treatment the determining factor in any eventual return. Philadelphia said it anticipates Hurts will have an opportunity to resume contact football activities once he is off blood thinners, but it provided no timetable for when that might occur.
Advertisement
The outlook for his recovery was the most encouraging part of the announcement. The Eagles and Lynn described his prognosis as very good, said they expect a full recovery and anticipate no long-term effects. Hurts is expected to remain involved with the team and continue conditioning during his absence, according to the statement.
The update comes as Philadelphia attempts to recover from a fourth consecutive loss. Tanner McKee started Sunday's 25-14 defeat against Carolina, completing 26 of 45 passes for 215 yards, one touchdown and no interceptions. The Eagles finished with 222 total yards, including 35 rushing yards, and fell to 2-4.
Philadelphia also has recently added Joe Milton as it adjusts its quarterback depth. McKee played every offensive snap against the Panthers, but the offense struggled to generate explosive gains despite productive returns from DeVonta Smith and Dallas Goedert.
Those football decisions now unfold alongside a more consequential priority: allowing Hurts to complete his treatment and recovery. The Eagles offered an encouraging long-term outlook Monday, even as the diagnosis leaves the team preparing for a potentially lengthy stretch without its starting quarterback.
This article originally appeared on Eagles Wire: Jalen Hurts expected to miss remainder of 2026 season due to blood clot
Source: “AOL Sports”
